轻松健康正式登陆港交所：上涨超135%，持续深化「检-医-药-康-险」生态闭环

Core Viewpoint - AI technology has become a significant growth engine for the company, which is positioned as a leading digital health and insurance service platform in China [4][5]. Group 1: IPO Details - The company officially listed on the Hong Kong Stock Exchange on December 23, 2025, under the stock code "2661" [2]. - A total of 26,540,000 shares were issued, with the Hong Kong public offering being oversubscribed by 1,421.47 times and the international offering by 2.9 times [2]. - The cornerstone investor, Guangdong Hengqin Guangdong-Macao Deep Cooperation Zone Aoqin Harmony Investment Partnership, subscribed for 100 million RMB [2]. Group 2: Financial Performance - As of 11:00 AM, the stock price reached HKD 53.40, representing an increase of over 135% from the issue price, with a market capitalization exceeding HKD 11 billion [3]. - Revenue figures for the company from 2022 to 2024 are projected to be 394 million RMB, 490 million RMB, and 945 million RMB, respectively, reflecting a compound annual growth rate (CAGR) of 54.9% [4]. - In the first half of this year, revenue grew by 84.7% year-on-year to 656 million RMB, with health service revenue accounting for 76.7% of total revenue [5]. Group 3: Market Position and User Base - The company ranks 10th in China's digital comprehensive health and health insurance market based on projected 2024 revenue, and 7th in the digital health service market [4]. - The total registered user base has reached 168.4 million, with 60.4% of users aged between 20 and 45, and a high user retention rate of 92.2% after 13 months [4]. Group 4: Strategic Focus - The funds raised from the IPO will primarily be used for AI technology upgrades, expansion of health service scenarios, and integration of the industry chain [5]. - The company aims to deepen the "testing-medical-pharmaceutical-health-insurance" ecosystem, leveraging the vast market potential of the digital health industry [5].